$SCWO
374Water Inc

2023 Q1 Form 10-K Financial Statement

#000165495423003036 Filed on March 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $801.5K $789.0K $3.016M
YoY Change 193.33% 5341.66% 6169.27%
Cost Of Revenue $720.1K $716.1K $2.679M
YoY Change 190.4%
Gross Profit $81.31K $72.90K $336.5K
YoY Change 222.09% 599.59%
Gross Profit Margin 10.15% 9.24% 11.16%
Selling, General & Admin $1.404M $1.441M $3.979M
YoY Change 96.83% 147.64% 176.33%
% of Gross Profit 1726.67% 1976.06% 1182.5%
Research & Development $355.9K $386.9K $1.114M
YoY Change 91.7% 267.64% 196.91%
% of Gross Profit 437.7% 530.73% 330.91%
Depreciation & Amortization $9.525K $17.52K $2.447K
YoY Change 3953.19% -41.09% -95.11%
% of Gross Profit 11.71% 24.03% 0.73%
Operating Expenses $1.760M $1.827M $5.093M
YoY Change 95.77% 166.03% 58.45%
Operating Profit -$1.679M -$1.755M -$4.756M
YoY Change 92.12% 50.22%
Interest Expense $37.86K $65.45K $67.07K
YoY Change 4407.14% 20353.12%
% of Operating Profit
Other Income/Expense, Net $38.24K -$910.00 $66.16K
YoY Change 4414.88% -375.76% 4626.0%
Pretax Income -$1.640M -$1.690M -$4.690M
YoY Change 87.93% 151.57% 48.2%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.640M -$1.690M -$4.690M
YoY Change 87.93% 151.57% 48.2%
Net Earnings / Revenue -204.67% -214.19% -155.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01 -$0.04
COMMON SHARES
Basic Shares Outstanding 127.3M shares 126.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.11M $5.991M $5.991M
YoY Change -1.16% -46.17% -46.17%
Cash & Equivalents $9.153M $4.047M
Short-Term Investments $1.961M $1.944M $1.944M
Other Short-Term Assets $130.2K $153.5K $153.5K
YoY Change -22.46% -29.76% -30.25%
Inventory $1.788M $1.661M $1.661M
Prepaid Expenses $130.2K $153.5K
Receivables $26.19K $918.2K $918.2K
Other Receivables $308.4K $0.00 $0.00
Total Short-Term Assets $15.04M $8.724M $8.724M
YoY Change 31.79% -23.14% -23.14%
LONG-TERM ASSETS
Property, Plant & Equipment $140.9K $143.1K $143.1K
YoY Change 3408.27% 14819.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.177M $1.193M $1.193M
YoY Change 12.0% 12.15% 12.56%
TOTAL ASSETS
Total Short-Term Assets $15.04M $8.724M $8.724M
Total Long-Term Assets $1.177M $1.193M $1.193M
Total Assets $16.22M $9.917M $9.917M
YoY Change 30.12% -20.11% -20.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $868.0K $1.450M $1.450M
YoY Change 502.61% 2201.65% 2315.97%
Accrued Expenses
YoY Change
Deferred Revenue $205.1K $200.1K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.073M $1.663M $1.663M
YoY Change 17.86% 1825.67% 1748.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.073M $1.663M $1.663M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.073M $1.663M $1.663M
YoY Change 17.86% 1825.67% 1748.02%
SHAREHOLDERS EQUITY
Retained Earnings -$9.490M -$7.850M
YoY Change 135.32% 148.42%
Common Stock $12.88K $12.67K
YoY Change 1.69% 1.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.14M $8.254M $8.254M
YoY Change
Total Liabilities & Shareholders Equity $16.22M $9.917M $9.917M
YoY Change 30.12% -20.11% -20.09%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$1.640M -$1.690M -$4.690M
YoY Change 87.93% 151.57% 48.2%
Depreciation, Depletion And Amortization $9.525K $17.52K $2.447K
YoY Change 3953.19% -41.09% -95.11%
Cash From Operating Activities -$3.178M -$2.351M -$4.949M
YoY Change -2842.17% 198.57% 168.83%
INVESTING ACTIVITIES
Capital Expenditures $7.303K $71.85K $144.6K
YoY Change 121.91% 6258.41% 12048.49%
Acquisitions
YoY Change
Other Investing Activities $4.037M -$1.963M
YoY Change 20255.82% -6644.77%
Cash From Investing Activities -$10.01K $3.965M -$2.160M
YoY Change 204.1% 18815.6% -7721.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $8.295M 25.05K $25.05K
YoY Change -99.5% -99.81%
NET CHANGE
Cash From Operating Activities -$3.178M -2.351M -$4.949M
Cash From Investing Activities -$10.01K 3.965M -$2.160M
Cash From Financing Activities $8.295M 25.05K $25.05K
Net Change In Cash $5.106M 1.639M -$7.084M
YoY Change 4434.03% -61.74% -164.06%
FREE CASH FLOW
Cash From Operating Activities -$3.178M -$2.351M -$4.949M
Capital Expenditures $7.303K $71.85K $144.6K
Free Cash Flow -$3.186M -$2.423M -$5.094M
YoY Change -2928.79% 207.25% 176.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000933972
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Trading Symbol
TradingSymbol
SCWO
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
27272 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.50
CY2022 scwo Weighted Average Remaining Contractual Life Years Beginning Balance
WeightedAverageRemainingContractualLifeYearsBeginningBalance
P2Y11M15D
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Entity File Number
EntityFileNumber
000-27866
CY2022 dei Entity Registrant Name
EntityRegistrantName
374WATER INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0271109
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
701 W Main Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 410,
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Durham
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27701
CY2022 dei City Area Code
CityAreaCode
919
CY2022 dei Local Phone Number
LocalPhoneNumber
888-8194
CY2022 dei Security12g Title
Security12gTitle
Common Stock, par value $0.0001 per share
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
372441831 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127344691 shares
CY2022 dei Auditor Firm
AuditorFirmId
677
CY2022 dei Auditor Name
AuditorName
CHERRY BEKAERT LLP
CY2022 dei Auditor Location
AuditorLocation
Raleigh, North Carolina
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4046937 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11131175 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
918164 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1660710 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2022Q4 us-gaap Investments
Investments
1944464 usd
CY2021Q4 us-gaap Investments
Investments
0 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
153455 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
218466 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8723730 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11349641 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
143079 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
959 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1050022 usd
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1062856 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1193101 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1063815 usd
CY2022Q4 us-gaap Assets
Assets
9916831 usd
CY2021Q4 us-gaap Assets
Assets
12413456 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1449582 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
62981 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200109 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
13528 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
23390 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1663219 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
86371 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1663219 usd
CY2021Q4 us-gaap Liabilities
Liabilities
86371 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
27272 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
3 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126702545 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125317746 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12669 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12531 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16110221 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15474566 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7849982 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3160015 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19296 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8253612 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12327085 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9916831 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12413456 usd
CY2022 us-gaap Revenues
Revenues
3015521 usd
CY2021 us-gaap Revenues
Revenues
48100 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
2679020 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
336501 usd
CY2021 us-gaap Gross Profit
GrossProfit
48100 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1113500 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
375032 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1644861 usd
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
0 usd
CY2022 scwo Product And Development Expenses
ProductAndDevelopmentExpenses
0 usd
CY2021 scwo Product And Development Expenses
ProductAndDevelopmentExpenses
1399833 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
768548 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
343862 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1565723 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1095381 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
5092632 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
3214108 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-4756131 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-3166008 usd
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
67067 usd
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
1066 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-903 usd
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
334 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
66164 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1400 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4689967 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3164608 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4689967 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3164608 usd
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-18968 usd
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-328 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19296 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4709263 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3164608 usd
CY2022 scwo Earnings Per Share Basics And Diluted
EarningsPerShareBasicsAndDiluted
-0.04
CY2021 scwo Earnings Per Share Basics And Diluted
EarningsPerShareBasicsAndDiluted
-0.03
CY2022 scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
126641536 shares
CY2021 scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
94002888 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11250 usd
CY2021 us-gaap Accretion Expense
AccretionExpense
204217 usd
CY2021 scwo Recapitalization Of The Company Amount
RecapitalizationOfTheCompanyAmount
-84225 usd
CY2021 scwo Issuance Of Stock Warrants For Development Of Product
IssuanceOfStockWarrantsForDevelopmentOfProduct
1399833 usd
CY2021 scwo Series D Preferred Stock Issued For Cash And Settlement Of Accounts Payable Amount
SeriesDPreferredStockIssuedForCashAndSettlementOfAccountsPayableAmount
6601745 usd
CY2021 scwo Exercised Option And Warrants Amount
ExercisedOptionAndWarrantsAmount
1285344 usd
CY2021 scwo Issuance Of Common Stock For License Rights Amount
IssuanceOfCommonStockForLicenseRightsAmount
1073529 usd
CY2021 scwo Conversion Of Convertible Preferred Shares Into Common Stock Amount
ConversionOfConvertiblePreferredSharesIntoCommonStockAmount
0 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3164608 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12327085 usd
CY2022 us-gaap Accretion Expense
AccretionExpense
610741 usd
CY2022 scwo Conversion Of Convertible Preferred Shares Into Common Stock Amount
ConversionOfConvertiblePreferredSharesIntoCommonStockAmount
-2 usd
CY2022 scwo Exercised Option And Warrants Amount
ExercisedOptionAndWarrantsAmount
25051 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-328 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-18968 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4689967 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8253612 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4689967 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3164608 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
67573 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46050 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
610741 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
204217 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-328 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2022 scwo Warrant Issued For Product Development Agreement
WarrantIssuedForProductDevelopmentAgreement
0 usd
CY2021 scwo Warrant Issued For Product Development Agreement
WarrantIssuedForProductDevelopmentAgreement
1399833 usd
CY2022 scwo Increase Decrease In Unbilled Accounts Receivable
IncreaseDecreaseInUnbilledAccountsReceivable
-918164 usd
CY2021 scwo Increase Decrease In Unbilled Accounts Receivable
IncreaseDecreaseInUnbilledAccountsReceivable
32330 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1660710 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
65011 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-238450 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1386601 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-142512 usd
CY2022 scwo Increase Decrease In Unearned Revenue
IncreaseDecreaseInUnearnedRevenue
200109 usd
CY2021 scwo Increase Decrease In Unearned Revenue
IncreaseDecreaseInUnearnedRevenue
0 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-9862 usd
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
22190 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4948996 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1840950 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
144567 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1190 usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1963432 usd
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
CY2022 us-gaap Proceeds From Previous Acquisition
ProceedsFromPreviousAcquisition
0 usd
CY2021 us-gaap Proceeds From Previous Acquisition
ProceedsFromPreviousAcquisition
113760 usd
CY2022 scwo Proceeds From Increase In Intangible Assets
ProceedsFromIncreaseInIntangibleAssets
-52292 usd
CY2021 scwo Proceeds From Increase In Intangible Assets
ProceedsFromIncreaseInIntangibleAssets
0 usd
CY2022 scwo Proceedsfrom Recapitalization Of The Company
ProceedsfromRecapitalizationOfTheCompany
0 usd
CY2021 scwo Proceedsfrom Recapitalization Of The Company
ProceedsfromRecapitalizationOfTheCompany
-84225 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2160291 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28345 usd
CY2022 scwo Repayments To Advances From Stockholders
RepaymentsToAdvancesFromStockholders
0 usd
CY2021 scwo Repayments To Advances From Stockholders
RepaymentsToAdvancesFromStockholders
-15108 usd
CY2022 scwo Proceeds From Series D Preferred Shares
ProceedsFromSeriesDPreferredShares
0 usd
CY2021 scwo Proceeds From Series D Preferred Shares
ProceedsFromSeriesDPreferredShares
6601745 usd
CY2022 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
CY2021 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
5000000 usd
CY2022 scwo Proceeds From Exercise Of Options
ProceedsFromExerciseOfOptions
25049 usd
CY2021 scwo Proceeds From Exercise Of Options
ProceedsFromExerciseOfOptions
42845 usd
CY2022 scwo Proceeds From Exercise Of Warrants
ProceedsFromExerciseOfWarrants
0 usd
CY2021 scwo Proceeds From Exercise Of Warrants
ProceedsFromExerciseOfWarrants
1242499 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25049 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12871981 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7084238 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11059376 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11131175 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71799 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4046937 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11131175 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 scwo Non Cash Transaction Change In Unrealized Loss On Marketable Securities
NonCashTransactionChangeInUnrealizedLossOnMarketableSecurities
18968 usd
CY2021 scwo Non Cash Transaction Change In Unrealized Loss On Marketable Securities
NonCashTransactionChangeInUnrealizedLossOnMarketableSecurities
0 usd
CY2022 scwo Non Cash Transaction Issuance Of Common Stock For License Rights
NonCashTransactionIssuanceOfCommonStockForLicenseRights
0 usd
CY2021 scwo Non Cash Transaction Issuance Of Common Stock For License Rights
NonCashTransactionIssuanceOfCommonStockForLicenseRights
1073529 usd
CY2022 scwo Non Cash Transaction Accounts Payable Settled With Series D Preferred Stock
NonCashTransactionAccountsPayableSettledWithSeriesDPreferredStock
0 usd
CY2021 scwo Non Cash Transaction Accounts Payable Settled With Series D Preferred Stock
NonCashTransactionAccountsPayableSettledWithSeriesDPreferredStock
50000 usd
CY2022 scwo Noncash Or Part Noncash Acquisition Cash
NoncashOrPartNoncashAcquisitionCash
0 usd
CY2021 scwo Noncash Or Part Noncash Acquisition Cash
NoncashOrPartNoncashAcquisitionCash
29536 usd
CY2022 scwo Noncash Or Part Noncash Acquisition Prepaid Expense
NoncashOrPartNoncashAcquisitionPrepaidExpense
0 usd
CY2021 scwo Noncash Or Part Noncash Acquisition Prepaid Expense
NoncashOrPartNoncashAcquisitionPrepaidExpense
14483 usd
CY2022 scwo Accounts Receivable
AccountsReceivable
0 usd
CY2021 scwo Accounts Receivable
AccountsReceivable
1000 usd
CY2022 scwo Noncash Or Part Noncash Acquisition Accounts Payable
NoncashOrPartNoncashAcquisitionAccountsPayable
0 usd
CY2021 scwo Noncash Or Part Noncash Acquisition Accounts Payable
NoncashOrPartNoncashAcquisitionAccountsPayable
-46150 usd
CY2022 scwo Noncash Or Part Noncash Acquisition Accrued Expenses
NoncashOrPartNoncashAcquisitionAccruedExpenses
0 usd
CY2021 scwo Noncash Or Part Noncash Acquisition Accrued Expenses
NoncashOrPartNoncashAcquisitionAccruedExpenses
-83094 usd
CY2022 scwo Noncash Or Part Noncash Acquisition Net Liability Assumed
NoncashOrPartNoncashAcquisitionNetLiabilityAssumed
0 usd
CY2021 scwo Noncash Or Part Noncash Acquisition Net Liability Assumed
NoncashOrPartNoncashAcquisitionNetLiabilityAssumed
-84225 usd
CY2022Q4 us-gaap Cash
Cash
1182412 usd
CY2022Q4 scwo Cash Adjusted Cost
CashAdjustedCost
6010369 usd
CY2022Q4 scwo Unrealized Losses
UnrealizedLosses
18968 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
5991401 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4046937 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1944464 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
0 usd
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
559481 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4400000 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1700000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1450000 usd
CY2022 us-gaap Reclassifications
Reclassifications
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain reclassifications of prior year amounts including other assets of $34,742 and intangible asset, net of $1,028,114 on the consolidated balance sheet have been made to conform to the 2022 presentation.  These reclassifications had no effect on net loss or loss per share as previously reported.</p>
CY2022Q4 us-gaap Other Assets
OtherAssets
34742 usd
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
1028114 usd
CY2022 us-gaap Depreciation
Depreciation
2447 usd
CY2021 us-gaap Depreciation
Depreciation
635 usd
CY2021 scwo Income Tax Rate Reconciliation Change In State Tax
IncomeTaxRateReconciliationChangeInStateTax
0 pure
CY2022 scwo Income Tax Reconciliation Change In Valuation Allowance
IncomeTaxReconciliationChangeInValuationAllowance
-0.2059 pure
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  Our customer revenue for one customer made up over 90% of revenue for the year ended December 31, 2022. One customer made up approximately 50% of our total revenue for the year ended 2021.  In 2022, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC. </p>
CY2022 scwo Revenues From Sales
RevenuesFromSales
2952020 usd
CY2022 scwo Revenues From Sale Of Treatability Services
RevenuesFromSaleOfTreatabilityServices
63501 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1113500 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
375032 usd
CY2021 scwo Income Tax Reconciliation Change In Valuation Allowance
IncomeTaxReconciliationChangeInValuationAllowance
-0.2216 pure
CY2022 scwo Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
-0.0180 pure
CY2021 scwo Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
-0.1226 pure
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, revenue, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.</p>
CY2022Q4 us-gaap Capital
Capital
7060511 usd
CY2021Q4 us-gaap Capital
Capital
11263270 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7849982 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3160015 usd
CY2022 scwo Net Income Loss1
NetIncomeLoss1
-4689967 usd
CY2022 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
4948996 usd
scwo Net Income Loss1
NetIncomeLoss1
-3164608 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
1840950 usd
CY2022 scwo Income Tax Reconciliation State Taxes
IncomeTaxReconciliationStateTaxes
0.0205 pure
CY2021 scwo Income Tax Reconciliation State Taxes
IncomeTaxReconciliationStateTaxes
0.0198 pure
CY2022 scwo Income Tax Reconciliation Other
IncomeTaxReconciliationOther
-0.0068 pure
CY2021 scwo Income Tax Reconciliation Other
IncomeTaxReconciliationOther
0.1144 pure
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
755218 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
0 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
905492 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1660710 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1062856 usd
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
52292 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
65126 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1050022 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
1108271 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
45415 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1062856 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
67500 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
67500 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
67500 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
67500 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
67500 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
712522 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1050022 usd
CY2022 scwo Revenue Percentage
RevenuePercentage
1 pure
CY2022 us-gaap Revenues
Revenues
3015521 usd
CY2021 us-gaap Revenues
Revenues
48100 usd
CY2021 scwo Revenue Percentage
RevenuePercentage
1 pure
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2022 scwo Billings Deferred Unearned Revenue
BillingsDeferredUnearnedRevenue
1467189 usd
CY2021 scwo Billings Deferred Unearned Revenue
BillingsDeferredUnearnedRevenue
0 usd
CY2022 scwo Recognition Of Prior Unearned Revenue
RecognitionOfPriorUnearnedRevenue
-1267080 usd
CY2021 scwo Recognition Of Prior Unearned Revenue
RecognitionOfPriorUnearnedRevenue
0 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200109 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2022 scwo Services Performed But Unbilled
ServicesPerformedButUnbilled
918164 usd
CY2021 scwo Services Performed But Unbilled
ServicesPerformedButUnbilled
0 usd
CY2022 scwo Services Billed
ServicesBilled
0 usd
CY2021 scwo Services Billed
ServicesBilled
0 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
918164 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 scwo Blank Check Preferred Stock
BlankCheckPreferredStock
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126702545 shares
CY2022 scwo Stock In Excess Percentage Of Outstanding Share
StockInExcessPercentageOfOutstandingShare
0.05 pure
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2056259 usd
CY2022 scwo Unrecognized Compensation Vesting Period
UnrecognizedCompensationVestingPeriod
four years
CY2021Q2 scwo Number Of Warrant Purchase
NumberOfWarrantPurchase
3783333 shares
CY2021Q2 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.30
CY2021Q2 scwo Share Based Compensation Arrangement By Share Based Payment Award In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardInPeriodWeightedAverageGrantDateFairValue
0.37
CY2021Q2 scwo Aggregate Fair Value Of Warrant
AggregateFairValueOfWarrant
1399833 usd
CY2021Q4 scwo Stock Issued Upon Warrant Exercised
StockIssuedUponWarrantExercised
3783333 shares
CY2021Q4 scwo Proceeds From Stock Issued Upon Warrants Exercised Amount
ProceedsFromStockIssuedUponWarrantsExercisedAmount
1134499 usd
CY2022Q4 scwo Warrants Outstanding Series One Shares
WarrantsOutstandingSeriesOneShares
1250000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
450000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
950000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.11
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
690500 usd
CY2021 scwo Weighted Average Remaining Contractual Life Years Beginning Balance
WeightedAverageRemainingContractualLifeYearsBeginningBalance
P0Y5M8D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5033333 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.85
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
4733333 shares
CY2021 scwo Weighted Average Exercise Price Exercised
WeightedAverageExercisePriceExercised
0.26
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.50
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
437500 usd
CY2021 scwo Weighted Average Remaining Contractual Life Years Ending Balance
WeightedAverageRemainingContractualLifeYearsEndingBalance
P2Y11M15D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2022 scwo Weighted Average Exercise Price Exercised
WeightedAverageExercisePriceExercised
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.50
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
450000 usd
CY2022 scwo Weighted Average Remaining Contractual Life Years Ending Balance
WeightedAverageRemainingContractualLifeYearsEndingBalance
P1Y11M15D
CY2022 us-gaap Related Party Costs
RelatedPartyCosts
1318117 usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
168897 usd
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
208742 usd
CY2022Q4 scwo Deferred Tax Assets Startup Cost
DeferredTaxAssetsStartupCost
65305 usd
CY2021Q4 scwo Deferred Tax Assets Startup Cost
DeferredTaxAssetsStartupCost
83710 usd
CY2022Q4 scwo Other Intangibles
OtherIntangibles
8068 usd
CY2021Q4 scwo Other Intangibles
OtherIntangibles
10339 usd
CY2022Q4 scwo Other Accruals
OtherAccruals
17425 usd
CY2021Q4 scwo Other Accruals
OtherAccruals
1875 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
80374 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
17423 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1009495 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
381112 usd
CY2022Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
346 usd
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
10499 usd
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
0 usd
CY2022Q4 scwo Deferred Tax Assets Unearned Revenue
DeferredTaxAssetsUnearnedRevenue
5763 usd
CY2021Q4 scwo Deferred Tax Assets Unearned Revenue
DeferredTaxAssetsUnearnedRevenue
0 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
353746 usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1698920 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
703211 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1665938 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
703083 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
32982 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
128 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-32982 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-128 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
32982 usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
128 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2022 scwo Income Tax Rate Reconciliation Change In State Tax
IncomeTaxRateReconciliationChangeInStateTax
0.0002 pure
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
10000.00 usd

Files In Submission

Name View Source Status
0001654954-23-003036-index-headers.html Edgar Link pending
0001654954-23-003036-index.html Edgar Link pending
0001654954-23-003036.txt Edgar Link pending
0001654954-23-003036-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scwo-20221231.xsd Edgar Link pending
scwo_10k.htm Edgar Link pending
scwo_ex211.htm Edgar Link pending
scwo_ex231.htm Edgar Link pending
scwo_ex311.htm Edgar Link pending
scwo_ex312.htm Edgar Link pending
scwo_ex321.htm Edgar Link pending
scwo_ex322.htm Edgar Link pending
Show.js Edgar Link pending
scwo-20221231_cal.xml Edgar Link unprocessable
scwo-20221231_def.xml Edgar Link unprocessable
scwo-20221231_lab.xml Edgar Link unprocessable
scwo-20221231_pre.xml Edgar Link unprocessable
scwo_10k_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable